You are in:Home/Publications/Molecular detection of fmdv serotype a isolated from the egyptian delta during 2019-2020

Dr. Zeinab Reda Ahmed Abo Ezz :: Publications:

Title:
Molecular detection of fmdv serotype a isolated from the egyptian delta during 2019-2020
Authors: GA Abdelmonem, Z Aboezz, A Habashi, S Sharawi
Year: 2022
Keywords: FMDV, Serotype A, Genotype IV, VP1gene, phylogenic analysis
Journal: Advances in Animal and Veterinary Sciences
Volume: 10
Issue: 9
Pages: 1924-1932
Publisher: Not Available
Local/International: Local
Paper Link:
Full paper Not Available
Supplementary materials Not Available
Abstract:

Egypt is one of the countries threaten with foot and mouth disease virus (FMDV) that attacks animals every year. The introduction of new topotypes/lineages of the existing FMD viruses represents a constant risk for cattle production. Serotype A is one of FMDV that is already existing and incriminated lastly in serval problems in cattle population. So, this study aimed at molecular characterization of serotype A FMDV that has been involved in the latest FMD outbreaks in Egypt. Thirty-six samples (26 blood and 10 oral epithelial tissue samples) were obtained from suspected cattle in three Egyptian governorates during 2019-2020. The samples were screened for FMDV by means of real‑time RT‑PCR that showed nearly 86% (n=31) of the examined samples to be FMDV positive. Virus isolation was carried out on ten of the FMDV positive samples that were selected according to their cycle threshold (Ct ) values. Moreover, the serotype A amplicons were subjected to sequencing of the VP1 gene. Through phylogenic analysis of three FMDV serotype A isolates, it has been deduced that two isolates were clustered to Asian Iran-05 topotype with close similarities (99.42-99.57%) to the local vaccine strain, while the other one belonged to African topotype genotype IV (GIV) and was genetically different from the local vaccine strain with 85.65% identity. These findings support the suggestion of adding the African topotype GIV as a supplementary vaccine to the currently used one.

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus